The Stomatitis (Sore Mouth) drugs in development market research report provides comprehensive information on the therapeutics under development for Stomatitis (Sore Mouth), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Stomatitis (Sore Mouth). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Stomatitis (Sore Mouth) and features dormant and discontinued products.
GlobalData tracks 17 drugs in development for Stomatitis (Sore Mouth) by 15 companies/universities/institutes. The top development phase for Stomatitis (Sore Mouth) is preclinical with nine drugs in that stage. The Stomatitis (Sore Mouth) pipeline has 15 drugs in development by companies and two by universities/ institutes. Some of the companies in the Stomatitis (Sore Mouth) pipeline products market are: Destiny Pharma, GlycoMira Therapeutics and iNtRON Biotechnology.
The key targets in the Stomatitis (Sore Mouth) pipeline products market include P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP), NACHT LRR And PYD Domains Containing Protein 3 (Caterpiller Protein 1.1 or Cold Autoinflammatory Syndrome 1 Protein or Cryopyrin or Nucleotide Binding Oligomerization Domain Leucine Rich Repeat And Pyrin Domain Containing 3 or NLRP3), and Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1).
The key mechanisms of action in the Stomatitis (Sore Mouth) pipeline product include P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) Inhibitor with two drugs in Preclinical. The Stomatitis (Sore Mouth) pipeline products include eight routes of administration with the top ROA being Oral and two key molecule types in the Stomatitis (Sore Mouth) pipeline products market including Small Molecule, and Recombinant Protein.
Stomatitis (Sore Mouth) overview
Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the mucous membranes of the mouth and lips, with or without oral ulceration. The inflammation can be the result of conditions within the mouth itself, such as poor oral hygiene, poorly fitted dentures, or mouth burns from hot food or drinks. It may also be caused by conditions that affect the entire body, such as medications, allergic reactions, or infections. A form of stomatitis known as stomatitis nicotina can be caused by smoking cigars, cigarettes, and/or pipes, and is characterized by small red bumps on the roof of the mouth. Causes include Nutritional deficiency, Aphthous stomatitis, dentures, Allergic contact stomatitis etc.
For a complete picture of Stomatitis (Sore Mouth)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
